« Not All Bruton’s Tyrosine Kinase Inhibitors Are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-Covalent BTK Inhibitors ». Actualité hématologique au Canada 5, no. s02 (mai 20, 2026): 2–7. Consulté le mai 21, 2026. https://canadianhematologytoday.com/article/view/5-s02-Minotti.